{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["GPR119", "TGR5", "imperatorin", "sitagliptin", "transfection", "triamterene"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29084156", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "30"}], "Language": ["eng"], "ELocationID": ["1192", "10.3390/nu9111192"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "9", "Issue": "11", "PubDate": {"Year": "2017", "Month": "Oct", "Day": "30"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.", "Abstract": {"AbstractText": ["Imperatorin, a dietary furocoumarin, is found not only in medicinal plants, but also in popular culinary herbs, such as parsley and fennel. Recently, imperatorin has been shown to activate GPR119 in cells. Another GPR, GPR131, also called TGR5 or G-protein-coupled bile acid receptor 1 (GPBAR1), is known to regulate glucose metabolism. Additionally, TGR5 activation increases glucagon-like peptide (GLP-1) secretion to lower blood sugar levels in animals. Therefore, the present study aims to determine whether the effects of imperatorin on GLP-1 secretion are mediated by TGR5. First, we transfected cultured Chinese hamster ovary cells (CHO-K1 cells) with the TGR5 gene. Glucose uptake was confirmed in the transfected cells using a fluorescent indicator. Moreover, NCI-H716 cells, which secrete GLP-1, were used to investigate the changes in calcium concentrations and GLP-1 levels. In addition, streptozotocin (STZ)-induced type 1-like diabetic rats were used to identify the effects of imperatorin in vivo. Imperatorin dose-dependently increased glucose uptake in CHO-K1 cells expressing TGR5. In STZ diabetic rats, similar to the results in NCI-H716 cells, imperatorin induced a marked increase of GLP-1 secretion that was reduced, but not totally abolished, by a dose of triamterene that inhibited TGR5. Moreover, increases in GLP-1 secretion induced by imperatorin and GPR119 activation were shown in NCI-H716 cells. We demonstrated that imperatorin induced GLP-1 secretion via activating TGR5 and GPR119. Therefore, imperatorin shall be considered as a TGR5 and GPR119 agonist."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Childhood Education and Nursery, Chia Nan University of Pharmacy and Science, Rende, Tainan City 71710, Taiwan. linyu870203@gmail.com."}, {"Identifier": [], "Affiliation": "Division of Pediatrics, Chi-Mei Medical Center, Yong Kang, Tainan City 71003, Taiwan. linyu870203@gmail.com."}, {"Identifier": [], "Affiliation": "Department of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City 81201, Taiwan. linyu870203@gmail.com."}], "LastName": "Wang", "ForeName": "Lin-Yu", "Initials": "LY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan. kc-cheng@m3.kufm.kagoshima-u.ac.jp."}], "LastName": "Cheng", "ForeName": "Kai-Chun", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8520, Japan. bebeli009@hotmail.com."}, {"Identifier": [], "Affiliation": "Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City 71003, Taiwan. bebeli009@hotmail.com."}], "LastName": "Li", "ForeName": "Yingxiao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Tzu Chi University of Science and Technology, Hualien City 97005, Taiwan. ncs@ems.tcust.edu.tw."}], "LastName": "Niu", "ForeName": "Chiang-Shan", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Research, Chi-Mei Medical Center, Yong Kang, Tainan City 71003, Taiwan. jtcheng@mail.cjcu.edu.tw."}, {"Identifier": [], "Affiliation": "Institute of Medical Science, College of Health Science, Chang Jung Christian University, Guei-Ren, Tainan City 71101, Taiwan. jtcheng@mail.cjcu.edu.tw."}], "LastName": "Cheng", "ForeName": "Juei-Tang", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nursing, Tzu Chi University of Science and Technology, Hualien City 97005, Taiwan. nhs580113@yahoo.com.tw."}], "LastName": "Niu", "ForeName": "Ho-Shan", "Initials": "HS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Furocoumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "GPR119 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Gpbar1 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, G-Protein-Coupled"}, {"RegistryNumber": "89750-14-1", "NameOfSubstance": "Glucagon-Like Peptide 1"}, {"RegistryNumber": "K713N25C78", "NameOfSubstance": "imperatorin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "CHO Cells"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cricetulus"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Furocoumarins"}, {"QualifierName": [], "DescriptorName": "Gene Silencing"}, {"QualifierName": ["blood"], "DescriptorName": "Glucagon-Like Peptide 1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptors, G-Protein-Coupled"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Akkati S., Sam K.G., Tungha G. Emergence of promising therapies in diabetes mellitus. J. Clin. Pharmacol. 2011;51:796\u2013804. doi: 10.1177/0091270010376972.", "ArticleIdList": ["10.1177/0091270010376972", "20705952"]}, {"Citation": "Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010;87:4\u201314. doi: 10.1016/j.diabres.2009.10.007.", "ArticleIdList": ["10.1016/j.diabres.2009.10.007", "19896746"]}, {"Citation": "Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet. 2005;365:1333\u20131346. doi: 10.1016/S0140-6736(05)61032-X.", "ArticleIdList": ["10.1016/S0140-6736(05)61032-X", "15823385"]}, {"Citation": "Prokopenko I., McCarthy M.I., Lindgren C.M. Type 2 diabetes: New genes, new understanding. Trends Genet. 2008;24:613\u2013621. doi: 10.1016/j.tig.2008.09.004.", "ArticleIdList": ["10.1016/j.tig.2008.09.004", "PMC7116807", "18952314"]}, {"Citation": "Kim W., Egan J.M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol. Rev. 2008;60:470\u2013512. doi: 10.1124/pr.108.000604.", "ArticleIdList": ["10.1124/pr.108.000604", "PMC2696340", "19074620"]}, {"Citation": "Baggio L.L., Drucker D.J. Biology of incretins: Glp-1 and gip. Gastroenterology. 2007;132:2131\u20132157. doi: 10.1053/j.gastro.2007.03.054.", "ArticleIdList": ["10.1053/j.gastro.2007.03.054", "17498508"]}, {"Citation": "Russell-Jones D., Gough S. Recent advances in incretin-based therapies. Clin. Endocrinol. (Oxf) 2012;77:489\u2013499. doi: 10.1111/j.1365-2265.2012.04483.x.", "ArticleIdList": ["10.1111/j.1365-2265.2012.04483.x", "22804841"]}, {"Citation": "Preeti Sen K.S., Prasad P., Chandrakar S., Sahu R.K., Roy A. Approach to phytochemistry and mechaniasm of action of plants having antidiabetic activity. UK J. Pharm. Biosci. 2016;4:82\u2013120."}, {"Citation": "Piao X.L., Park I.H., Baek S.H., Kim H.Y., Park M.K., Park J.H. Antioxidative activity of furanocoumarins isolated from angelicae dahuricae. J. Ethnopharmacol. 2004;93:243\u2013246. doi: 10.1016/j.jep.2004.03.054.", "ArticleIdList": ["10.1016/j.jep.2004.03.054", "15234759"]}, {"Citation": "Dong K., Ni H., Wu M., Tang Z., Halim M., Shi D. Ros-mediated glucose metabolic reprogram induces insulin resistance in type 2 diabetes. Biochem. Biophys. Res. Commun. 2016;476:204\u2013211. doi: 10.1016/j.bbrc.2016.05.087.", "ArticleIdList": ["10.1016/j.bbrc.2016.05.087", "27207834"]}, {"Citation": "Overton H.A., Fyfe M.C., Reynet C. Gpr119, a novel g protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br. J. Pharmacol. 2008;153(Suppl. S1):S76\u2013S81. doi: 10.1038/sj.bjp.0707529.", "ArticleIdList": ["10.1038/sj.bjp.0707529", "PMC2268073", "18037923"]}, {"Citation": "Park E.Y., Kim E.H., Kim C.Y., Kim M.H., Choung J.S., Oh Y.S., Moon H.S., Jun H.S. Angelica dahurica extracts improve glucose tolerance through the activation of gpr119. PLoS ONE. 2016;11:e0158796. doi: 10.1371/journal.pone.0158796.", "ArticleIdList": ["10.1371/journal.pone.0158796", "PMC4938581", "27391814"]}, {"Citation": "Lu X., Yuan Z.Y., Yan X.J., Lei F., Jiang J.F., Yu X., Yang X.W., Xing D.M., Du L.J. Effects of angelica dahurica on obesity and fatty liver in mice. Chin. J. Nat. Med. 2016;14:641\u2013652. doi: 10.1016/S1875-5364(16)30076-0.", "ArticleIdList": ["10.1016/S1875-5364(16)30076-0", "27667509"]}, {"Citation": "Adebajo A.C., Iwalewa E.O., Obuotor E.M., Ibikunle G.F., Omisore N.O., Adewunmi C.O., Obaparusi O.O., Klaes M., Adetogun G.E., Schmidt T.J., et al. Pharmacological properties of the extract and some isolated compounds of clausena lansium stem bark: Anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J. Ethnopharmacol. 2009;122:10\u201319. doi: 10.1016/j.jep.2008.11.015.", "ArticleIdList": ["10.1016/j.jep.2008.11.015", "19095054"]}, {"Citation": "Kawamata Y., Fujii R., Hosoya M., Harada M., Yoshida H., Miwa M., Fukusumi S., Habata Y., Itoh T., Shintani Y., et al. A g protein-coupled receptor responsive to bile acids. J. Biol. Chem. 2003;278:9435\u20139440. doi: 10.1074/jbc.M209706200.", "ArticleIdList": ["10.1074/jbc.M209706200", "12524422"]}, {"Citation": "Maruyama T., Miyamoto Y., Nakamura T., Tamai Y., Okada H., Sugiyama E., Nakamura T., Itadani H., Tanaka K. Identification of membrane-type receptor for bile acids (m-bar) Biochem. Biophys. Res. Commun. 2002;298:714\u2013719. doi: 10.1016/S0006-291X(02)02550-0.", "ArticleIdList": ["10.1016/S0006-291X(02)02550-0", "12419312"]}, {"Citation": "Pols T.W., Noriega L.G., Nomura M., Auwerx J., Schoonjans K. The bile acid membrane receptor tgr5 as an emerging target in metabolism and inflammation. J. Hepatol. 2011;54:1263\u20131272. doi: 10.1016/j.jhep.2010.12.004.", "ArticleIdList": ["10.1016/j.jhep.2010.12.004", "PMC3650458", "21145931"]}, {"Citation": "Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell. Biol. 2002;3:639\u2013650. doi: 10.1038/nrm908.", "ArticleIdList": ["10.1038/nrm908", "12209124"]}, {"Citation": "Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., et al. Tgr5-mediated bile acid sensing controls glucose homeostasis. Cell. Metab. 2009;10:167\u2013177. doi: 10.1016/j.cmet.2009.08.001.", "ArticleIdList": ["10.1016/j.cmet.2009.08.001", "PMC2739652", "19723493"]}, {"Citation": "Watanabe M., Houten S.M., Mataki C., Christoffolete M.A., Kim B.W., Sato H., Messaddeq N., Harney J.W., Ezaki O., Kodama T., et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484\u2013489. doi: 10.1038/nature04330.", "ArticleIdList": ["10.1038/nature04330", "16400329"]}, {"Citation": "Cheng J.T., Liu I.M., Chi T.C., Tzeng T.F., Lu F.H., Chang C.J. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 2001;50:2815\u20132821. doi: 10.2337/diabetes.50.12.2815.", "ArticleIdList": ["10.2337/diabetes.50.12.2815", "11723065"]}, {"Citation": "Lo S.H., Cheng K.C., Li Y.X., Chang C.H., Cheng J.T., Lee K.S. Development of betulinic acid as an agonist of tgr5 receptor using a new in vitro assay. Drug Des. Dev. Ther. 2016;10:2669\u20132676.", "ArticleIdList": ["PMC5001664", "27578964"]}, {"Citation": "Yamada K., Saito M., Matsuoka H., Inagaki N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nat. Protoc. 2007;2:753\u2013762. doi: 10.1038/nprot.2007.76.", "ArticleIdList": ["10.1038/nprot.2007.76", "17406637"]}, {"Citation": "Blodgett A.B., Kothinti R.K., Kamyshko I., Petering D.H., Kumar S., Tabatabai N.M. A fluorescence method for measurement of glucose transport in kidney cells. Diabetes Technol. Ther. 2011;13:743\u2013751. doi: 10.1089/dia.2011.0041.", "ArticleIdList": ["10.1089/dia.2011.0041", "PMC3118926", "21510766"]}, {"Citation": "Henke W., Cetinsoy C., Jung K., Loening S. Non-hyperbolic calcium calibration curve of fura-2: Implications for the reliability of quantitative ca2+ measurements. Cell Calcium. 1996;20:287\u2013292. doi: 10.1016/S0143-4160(96)90034-2.", "ArticleIdList": ["10.1016/S0143-4160(96)90034-2", "8894275"]}, {"Citation": "Lin J.W., Tsai C.C., Chen L.J., Niu H.S., Chang C.K., Niu C.S. Characterization of musclin as a new target for treatment of hypertension. Biomed. Res. Int. 2014;2014:354348. doi: 10.1155/2014/354348.", "ArticleIdList": ["10.1155/2014/354348", "PMC3966495", "24734231"]}, {"Citation": "Wang X.Y., Zhang S.Y., Li J., Liu H.N., Xie X., Nan F.J. Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective tgr5 agonists with improved cellular efficacy. Acta Pharmacol. Sin. 2014;35:1463\u20131472. doi: 10.1038/aps.2014.97.", "ArticleIdList": ["10.1038/aps.2014.97", "PMC4220082", "25283506"]}, {"Citation": "Anini Y., Brubaker P.L. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes. 2003;52:252\u2013259. doi: 10.2337/diabetes.52.2.252.", "ArticleIdList": ["10.2337/diabetes.52.2.252", "12540594"]}, {"Citation": "Jang H.J., Kokrashvili Z., Theodorakis M.J., Carlson O.D., Kim B.J., Zhou J., Kim H.H., Xu X., Chan S.L., Juhaszova M., et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc. Natl. Acad. Sci. USA. 2007;104:15069\u201315074. doi: 10.1073/pnas.0706890104.", "ArticleIdList": ["10.1073/pnas.0706890104", "PMC1986614", "17724330"]}, {"Citation": "Copple B.L., Li T. Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules. Pharmacol. Res. 2016;104:9\u201321. doi: 10.1016/j.phrs.2015.12.007.", "ArticleIdList": ["10.1016/j.phrs.2015.12.007", "PMC4900180", "26706784"]}, {"Citation": "Agarwal S., Patil A., Aware U., Deshmukh P., Darji B., Sasane S., Sairam K.V., Priyadarsiny P., Giri P., Patel H., et al. Discovery of a potent and orally efficacious tgr5 receptor agonist. ACS Med. Chem. Lett. 2016;7:51\u201355. doi: 10.1021/acsmedchemlett.5b00323.", "ArticleIdList": ["10.1021/acsmedchemlett.5b00323", "PMC4716599", "26819665"]}, {"Citation": "Li Y.C.K., Niu C., Lo S., Cheng J.T., Niu H. Investigation of triamterene as an inhibitor of the tgr5 receptor: Identification in cells and animals. Drug Des. Dev. Ther. 2017;11:1127\u20131134. doi: 10.2147/DDDT.S131892.", "ArticleIdList": ["10.2147/DDDT.S131892", "PMC5391213", "28435224"]}, {"Citation": "Genet C., Strehle A., Schmidt C., Boudjelal G., Lobstein A., Schoonjans K., Souchet M., Auwerx J., Saladin R., Wagner A. Structure-activity relationship study of betulinic acid, a novel and selective tgr5 agonist, and its synthetic derivatives: Potential impact in diabetes. J. Med. Chem. 2010;53:178\u2013190. doi: 10.1021/jm900872z.", "ArticleIdList": ["10.1021/jm900872z", "19911773"]}, {"Citation": "Kuhre R.E., Holst J.J., Kappe C. The regulation of function, growth and survival of glp-1-producing l-cells. Clin.Sci. 2016;130:79\u201391. doi: 10.1042/CS20150154.", "ArticleIdList": ["10.1042/CS20150154", "26637406"]}, {"Citation": "Drucker D.J. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action. Diabetes Care. 2007;30:1335\u20131343. doi: 10.2337/dc07-0228.", "ArticleIdList": ["10.2337/dc07-0228", "17337495"]}, {"Citation": "Salehi M., Aulinger B., Prigeon R.L., D\u2019Alessio D.A. Effect of endogenous glp-1 on insulin secretion in type 2 diabetes. Diabetes. 2010;59:1330\u20131337. doi: 10.2337/db09-1253.", "ArticleIdList": ["10.2337/db09-1253", "PMC2874693", "20215429"]}, {"Citation": "Smits M.M., Tonneijck L., Muskiet M.H., Kramer M.H., Cahen D.L., van Raalte D.H. Gastrointestinal actions of glucagon-like peptide-1-based therapies: Glycaemic control beyond the pancreas. Diabetes Obes. Metab. 2016;18:224\u2013235. doi: 10.1111/dom.12593.", "ArticleIdList": ["10.1111/dom.12593", "26500045"]}, {"Citation": "Dhanesha N., Joharapurkar A., Shah G., Dhote V., Kshirsagar S., Bahekar R., Jain M. Exendin-4 reduces glycemia by increasing liver glucokinase activity: An insulin independent effect. Pharmacol. Rep. 2012;64:140\u2013149. doi: 10.1016/S1734-1140(12)70740-5.", "ArticleIdList": ["10.1016/S1734-1140(12)70740-5", "22580530"]}, {"Citation": "Seghieri M., Rebelos E., Gastaldelli A., Astiarraga B.D., Casolaro A., Barsotti E., Pocai A., Nauck M., Muscelli E., Ferrannini E. Direct effect of glp-1 infusion on endogenous glucose production in humans. Diabetologia. 2013;56:156\u2013161. doi: 10.1007/s00125-012-2738-3.", "ArticleIdList": ["10.1007/s00125-012-2738-3", "23064290"]}, {"Citation": "Plummer M.P., Jones K.L., Annink C.E., Cousins C.E., Meier J.J., Chapman M.J., Horowitz M., Deane A.M. Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjects. Diabetes Care. 2014;37:1509\u20131515. doi: 10.2337/dc13-1813.", "ArticleIdList": ["10.2337/dc13-1813", "24598243"]}, {"Citation": "Retnakaran R., Kramer C.K., Choi H., Swaminathan B., Zinman B. Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: The libra trial. Diabetes Care. 2014;37:3270\u20133278. doi: 10.2337/dc14-0893.", "ArticleIdList": ["10.2337/dc14-0893", "25249651"]}, {"Citation": "Hansen M., Scheltema M.J., Sonne D.P., Hansen J.S., Sperling M., Rehfeld J.F., Holst J.J., Vilsboll T., Knop F.K. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion. Diabetes Obes. Metab. 2016;18:571\u2013580. doi: 10.1111/dom.12648.", "ArticleIdList": ["10.1111/dom.12648", "26888164"]}]}], "History": [{"Year": "2017", "Month": "9", "Day": "9"}, {"Year": "2017", "Month": "10", "Day": "26"}, {"Year": "2017", "Month": "10", "Day": "26"}, {"Year": "2017", "Month": "10", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29084156", "PMC5707664", "10.3390/nu9111192", "nu9111192"]}}]}